-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Aura Biosciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q4 2024.
- Aura Biosciences, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$27.8M, a 12.2% decline year-over-year.
- Aura Biosciences, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$96.1M, a 13.1% decline year-over-year.
- Aura Biosciences, Inc. annual Operating Income (Loss) for 2024 was -$96.1M, a 13.1% decline from 2023.
- Aura Biosciences, Inc. annual Operating Income (Loss) for 2023 was -$85M, a 41% decline from 2022.
- Aura Biosciences, Inc. annual Operating Income (Loss) for 2022 was -$60.3M, a 71.1% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)